495 related articles for article (PubMed ID: 29254099)
21. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage.
Baron JC; Farid K; Dolan E; Turc G; Marrapu ST; O'Brien E; Aigbirhio FI; Fryer TD; Menon DK; Warburton EA; Hong YT
J Cereb Blood Flow Metab; 2014 May; 34(5):753-8. PubMed ID: 24619277
[TBL] [Abstract][Full Text] [Related]
23. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.
Janelidze S; Pannee J; Mikulskis A; Chiao P; Zetterberg H; Blennow K; Hansson O
JAMA Neurol; 2017 Dec; 74(12):1492-1501. PubMed ID: 29114726
[TBL] [Abstract][Full Text] [Related]
24. Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria.
Renard D; Castelnovo G; Wacongne A; Le Floch A; Thouvenot E; Mas J; Gabelle A; Labauge P; Lehmann S
J Neurol; 2012 Nov; 259(11):2429-33. PubMed ID: 22576334
[TBL] [Abstract][Full Text] [Related]
25. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.
Álvarez I; Aguilar M; González JM; Ysamat M; Lorenzo-Bosquet C; Alonso A; Tartari JP; Romero S; Diez-Fairen M; Carcel M; Pujalte F; Pastor P
J Alzheimers Dis; 2018; 61(1):135-143. PubMed ID: 29154286
[TBL] [Abstract][Full Text] [Related]
26. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
[TBL] [Abstract][Full Text] [Related]
27. Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
Raposo N; Planton M; Péran P; Payoux P; Bonneville F; Lyoubi A; Albucher JF; Acket B; Salabert AS; Olivot JM; Hitzel A; Chollet F; Pariente J
Neurology; 2017 Aug; 89(7):697-704. PubMed ID: 28724587
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
[TBL] [Abstract][Full Text] [Related]
29. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.
Gurol ME; Viswanathan A; Gidicsin C; Hedden T; Martinez-Ramirez S; Dumas A; Vashkevich A; Ayres AM; Auriel E; van Etten E; Becker A; Carmasin J; Schwab K; Rosand J; Johnson KA; Greenberg SM
Ann Neurol; 2013 Apr; 73(4):529-36. PubMed ID: 23424091
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
Jang H; Park SB; Kim Y; Kim KW; Lee JI; Kim ST; Lee KH; Kang ES; Choe YS; Seo SW; Kim HJ; Kim YJ; Yoon CW; Na DL
J Neurol; 2018 Jan; 265(1):63-73. PubMed ID: 29128930
[TBL] [Abstract][Full Text] [Related]
31. CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.
Gao R; Zhang G; Chen X; Yang A; Smith G; Wong DF; Zhou Y
PLoS One; 2016; 11(10):e0164762. PubMed ID: 27764160
[TBL] [Abstract][Full Text] [Related]
32. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.
Rauchmann BS; Ghaseminejad F; Mekala S; Perneczky R;
Radiology; 2020 Jul; 296(1):134-142. PubMed ID: 32368960
[TBL] [Abstract][Full Text] [Related]
33. Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment.
Shams S; Granberg T; Martola J; Charidimou A; Li X; Shams M; Fereshtehnejad SM; Cavallin L; Aspelin P; Wiberg-Kristoffersen M; Wahlund LO
J Cereb Blood Flow Metab; 2017 Mar; 37(3):1006-1013. PubMed ID: 27178426
[TBL] [Abstract][Full Text] [Related]
34. Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.
Hake A; Trzepacz PT; Wang S; Yu P; Case M; Hochstetler H; Witte MM; Degenhardt EK; Dean RA;
Alzheimers Dement; 2015 Aug; 11(8):986-93. PubMed ID: 25916563
[TBL] [Abstract][Full Text] [Related]
35. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of Diagnosis and Treatment of 6 Cases of Cerebral Amyloid Angiopathy-related Inflammation].
Zhong D; Yang TH; Zhang Q; Wu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):107-112. PubMed ID: 31950799
[TBL] [Abstract][Full Text] [Related]
37. Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation: A Single-Institution 25-Year Experience.
Salvarani C; Morris JM; Giannini C; Brown RD; Christianson T; Hunder GG
Medicine (Baltimore); 2016 May; 95(20):e3613. PubMed ID: 27196463
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal Fluid Biomarkers in Dementia Patients with Cerebral Amyloid Angiopathy.
Li YF; Ge FF; Zhang Y; You H; Zhang ZX
Chin Med Sci J; 2015 Sep; 30(3):170-3. PubMed ID: 26564416
[TBL] [Abstract][Full Text] [Related]
39. Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation: A systematic analysis of published and seven new cases.
Szalardy L; Fakan B; Maszlag-Torok R; Ferencz E; Reisz Z; Radics BL; Csizmadia S; Szpisjak L; Annus A; Zadori D; Kovacs GG; Klivenyi P
Neuropathol Appl Neurobiol; 2024 Feb; 50(1):e12946. PubMed ID: 38093468
[TBL] [Abstract][Full Text] [Related]
40. White matter hyperintensities: relationship to amyloid and tau burden.
Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P
Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
